Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CELLULAR GOODS PLC AGM Information 2025

Jan 31, 2025

5058_egm_2025-01-31_627165e1-f2e6-448e-9492-c3226bbe9963.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4637V

Cel AI PLC

31 January 2025

31 January 2025

CEL AI plc

("Cel AI" or the "Company")

Notice of Annual General Meeting

Cel AI (LSE: CLAI), a company specialising in cutting-edge artificial intelligence (AI) to deliver tailored beauty advice and product recommendations as well as next-generation skincare and wellness products, announces it will hold its Annual General Meeting ("AGM") at 14:00 on 25 February 2025 at the offices of Fladgate LLP at 16 Great Queen Street, London, WC2B 5DG.

Details of the arrangements for this year's AGM are set out in the Notice of AGM. The Notice of AGM, together with a Form of Proxy, will be posted to shareholders today. The Notice of AGM will shortly also be available on the Company's website at  https://www.getcel.ai/investors   .

For further information please contact:

Cel AI
Director

Michael Edwards
via FSCF
First Sentinel Corporate Finance (FSCF)
Corporate Advisor

Brian Stockbridge
+44 7858 888 007

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOASDISUFEISEEF